Skip to content

PHARMA PARTNERS

Inactive KBO/BCE: BE 0441.835.592 subsidiary of McKesson Europe

Last board

1 director, last change in 2020
Director
appointed by deed of 27-11-2020
also on the board of 7 other companies

Office holders in the KBO →

Mandates through the years

2 names, the dashed line is today
BoardEarliermandate already running before its first mention
Mandates as a list
  • Arnaud Berken
    • Director, appointed by deed of 27-11-2020, still in office
  • Alain Charlier
    • Director, until 01-09-2020

Control

Consolidating parent
McKesson Europe DE
consolidates
This company
PHARMA PARTNERS
Equity €23.5m
Loss €2,976 in 2020

Further up the chainMc Kesson Corporation US consolidates

and 2 other shareholders

Capital

Capital
€9,953,000
Shares
40,147
Contribution per share
€248
Equity per share
€587 in 2020
Source
deed of 27-11-2020

Owners through the years

as the annual accounts name them
OCP SA FR
100%
Mc Kesson Corporation US
consolidates
McKesson Europe DE
consolidates
CELESIO AG DE
consolidates until 2017
Owners as a list

Source: shareholder structure in its own accounts, parent in its own accounts

Articles of association

deed of 27-11-2020 (in French)
Financial yearThe company draws up its annual accounts over this twelve-month period.
From 1 April to 31 March

Shareholders

3 owners

Owners 3

Next steps